Holista Colltech Limited (ASX:HCT)

5.4¢

right-arrow Created with Sketch. 0.002 (3.85%)
MCAP $14.86M
Last trade 16.10pm 26/11/2021 20mins delayed

Latest Announcements

12/11/2021HCTHolista Colltech Limited
29/10/2021 Price SensitivePSHCTHolista Colltech Limited
29/10/2021 Price SensitivePSHCTHolista Colltech Limited
29/10/2021HCTHolista Colltech Limited
12/10/2021 Price SensitivePSHCTHolista Colltech Limited
11/10/2021 Price SensitivePSHCTHolista Colltech Limited
2,843
MCap
11/10/2021 Price SensitivePSHCTHolista Colltech Limited
413
MCap
16/09/2021HCTHolista Colltech Limited

Company Overview

Holista CollTech Ltd is a research-driven biotech company. The Company is focused on researching, developing, manufacturing, and marketing health-style products. The Company's segments include Supplements, Ovine collagen, Food ingredients, and Infection control. The Supplements segment is engaged in the manufacture and wholesale distribution of dietary supplements. Ovine collagen is engaged in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is engaged in the manufacture and wholesale distribution of healthy food ingredients. Infection control segment is engaged in the infection control solutions. Its Path-Away technology is developed from bioflavonoids, which kill approximately 170 viruses, bacteria and fungi-naturally and without side effects. The Company's products include M3 System, FogClean, OVICOLL 98, OVICOLL 95, OVINEX and GILite.

HCT in the news

Holista Colltech’s (HCT) subsidiary signs a non-binding collaboration term sheet with Country…
ASIC is taking Holista Coltech (HCT) to court over allegations the company…
Holista CollTech (HCT) subsidiary Holista Biotech has signed an exclusive distribution agreement…
Small-cap biotech Holista CollTech (HCT) has been hit with a defamation suit…

Search Previous Announcements